1431 related articles for article (PubMed ID: 29130504)
1. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
Luan H; Wang X; Cai Z
Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
[TBL] [Abstract][Full Text] [Related]
2. Metabolome analysis for investigating host-gut microbiota interactions.
Chen MX; Wang SY; Kuo CH; Tsai IL
J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S10-S22. PubMed ID: 30269936
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.
Xie G; Zhang S; Zheng X; Jia W
Electrophoresis; 2013 Oct; 34(19):2787-98. PubMed ID: 23775228
[TBL] [Abstract][Full Text] [Related]
4. Targeted metabolomics for the quantitative measurement of 9 gut microbiota-host co-metabolites in rat serum, urine and feces by liquid chromatography-tandem mass spectrometry.
Zeng Y; Lin Y; Li L; Li Y; Zhang X; Wang M; Chen Y; Luo L; Lu B; Xie Z; Liao Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():133-143. PubMed ID: 30807966
[TBL] [Abstract][Full Text] [Related]
5. Challenges of metabolomics in human gut microbiota research.
Smirnov KS; Maier TV; Walker A; Heinzmann SS; Forcisi S; Martinez I; Walter J; Schmitt-Kopplin P
Int J Med Microbiol; 2016 Aug; 306(5):266-279. PubMed ID: 27012595
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases.
Konjevod M; Nikolac Perkovic M; Sáiz J; Svob Strac D; Barbas C; Rojo D
J Pharm Biomed Anal; 2021 Feb; 194():113681. PubMed ID: 33279302
[TBL] [Abstract][Full Text] [Related]
7. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
[TBL] [Abstract][Full Text] [Related]
8. A strategy for the targeted metabolomics analysis of 11 gut microbiota-host co-metabolites in rat serum, urine and feces by ultra high performance liquid chromatography-tandem mass spectrometry.
Hou W; Zhong D; Zhang P; Li Y; Lin M; Liu G; Yao M; Liao Q; Xie Z
J Chromatogr A; 2016 Jan; 1429():207-17. PubMed ID: 26733392
[TBL] [Abstract][Full Text] [Related]
9. Assessment of gut microbiota fecal metabolites by chromatographic targeted approaches.
Fiori J; Turroni S; Candela M; Gotti R
J Pharm Biomed Anal; 2020 Jan; 177():112867. PubMed ID: 31614303
[TBL] [Abstract][Full Text] [Related]
10. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease.
Kong G; Ellul S; Narayana VK; Kanojia K; Ha HTT; Li S; Renoir T; Cao KL; Hannan AJ
Neurobiol Dis; 2021 Jan; 148():105199. PubMed ID: 33249136
[TBL] [Abstract][Full Text] [Related]
11. Microbiome-Metabolomics Analysis of the Impacts of Long-Term Dietary Advanced-Glycation-End-Product Consumption on C57BL/6 Mouse Fecal Microbiota and Metabolites.
Qu W; Nie C; Zhao J; Ou X; Zhang Y; Yang S; Bai X; Wang Y; Wang J; Li J
J Agric Food Chem; 2018 Aug; 66(33):8864-8875. PubMed ID: 30037223
[TBL] [Abstract][Full Text] [Related]
12. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
Spielman LJ; Gibson DL; Klegeris A
Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
[TBL] [Abstract][Full Text] [Related]
13. Acute oral methylmercury exposure perturbs the gut microbiome and alters gut-brain axis related metabolites in rats.
Lin X; Zhao J; Zhang W; He L; Wang L; Chang D; Cui L; Gao Y; Li B; Chen C; Li YF
Ecotoxicol Environ Saf; 2020 Mar; 190():110130. PubMed ID: 31918252
[TBL] [Abstract][Full Text] [Related]
14. Mass Spectrometry-Based Microbial Metabolomics: Techniques, Analysis, and Applications.
Baidoo EEK; Teixeira Benites V
Methods Mol Biol; 2019; 1859():11-69. PubMed ID: 30421222
[TBL] [Abstract][Full Text] [Related]
15. Measurement of gut microbial metabolites in cardiometabolic health and translational research.
Wu WK; Hsu CC; Sheen LY; Wu MS
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8537. PubMed ID: 31344762
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Profiling of Fecal Metabolome of Mice by Integrated Chemical Isotope Labeling-Mass Spectrometry Analysis.
Yuan BF; Zhu QF; Guo N; Zheng SJ; Wang YL; Wang J; Xu J; Liu SJ; He K; Hu T; Zheng YW; Xu FQ; Feng YQ
Anal Chem; 2018 Mar; 90(5):3512-3520. PubMed ID: 29406693
[TBL] [Abstract][Full Text] [Related]
17. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP
Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304
[TBL] [Abstract][Full Text] [Related]
18. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
19. Gut microbial metabolites as multi-kingdom intermediates.
Krautkramer KA; Fan J; Bäckhed F
Nat Rev Microbiol; 2021 Feb; 19(2):77-94. PubMed ID: 32968241
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications.
Raja G; Gupta H; Gebru YA; Youn GS; Choi YR; Kim HS; Yoon SJ; Kim DJ; Kim TJ; Suk KT
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
